We are delighted Miles Jones, MEPC Development Manager is running for us in the London Marathon he is hoping to raise £1,500.
Please click on link to donate:-
From 1st January the Committee has decided the booking of all appointments shall be as follows:
MS members can book up to 6 weeks in advance
Non-ms members/carers can book up to 3 weeks in advance
This will go some way to reinforcing that MS members take priority.
If you are visiting the new Westgate Centre in Oxford please visit John Lewis, pick up and complete a ‘Community Matters’ scheme application form and post in the relevant box. Every 3 months each John Lewis shop selects 3 community groups to help. Customers are directly involved in deciding how much each nominated group receives, by using a token to vote for the organisation they’d like to support.
Tickets are on sale for our Christmas Raffle. Draw to be held at the Xmas Lunch on 13th December. tickets £5 a strip. Prizes include:
– Therapy Sessions
– £25 off food and drink at The Fleur, East Hagbourne
– Neals Yard skincare kit
– Jigsaw puzzle
– Avon Gift Balls
– Wine, sherry and more
– Christmas lunch is being held on 13th December at noon, Park Place Brasserie. 2 courses £18, 3 courses £16 (inc tip). Numbers needed BY END OF NOVEMBER. Menu available to see on reception desk, please write your name down and pay £5 deposit by END OF NOVEMBER to confirm your place.
– Christmas Cards. We have a new selection of cards, chosen by members, £3 for a pack of 10.
– Christmas Raffle. Being held at the Christmas Lunch. Tickets £5 a strip or £1 each. Prizes include: £25 off food/drink at The Fleur, East Hagbourne, Champagne, Therapy Sessions, Biscuits, Wine, chocolates etc
On Channel 4 on Thursday night at 10pm programme about stem cell use in MS Patients.
From January Tim our Acupuncturist will be coming to the Centre twice a month on the 1st and 3rd Thursday. If you would like more information on the types of acupuncture he does please let Sue know.
Source Mutiple Sclerosis News Today:
In the future, a blood test may make diagnosing multiple sclerosis (MS) much easier, thanks to newly identified biomarker patterns that distinguish between MS patients and healthy people.
The test could also correctly detect primary progressive MS (PPMS) in patients who also had relapsing-remitting disease (RRMS).
Australian researchers suggest that their test — if validated in future prospective studies — could also be used to predict the disease subtype from the outset, or potentially spot the transformation from relapsing to progressive disease earlier than current clinical tests.
This could be particularly important since the emergence of newer-generation treatments — which address axon and brain volume loss — may allow treatment choices that potentially slow disease progression, the research team said. Read on.
Source MS Society:
A new oral treatment for relapsing MS, called cladribine, will be made available on the NHS in England and Wales within the next three months.
Decision makers in Scotland and Northern Ireland are still considering whether to make cladribine available on the NHS.
Cladribine (also known as Mavenclad) is the thirteenth treatment to be approved by the National Institute for Health and Care Excellence (NICE) for relapsing MS. Unlike other oral treatments, which need to be taken every day, cladribine is taken as two courses of tablets, one year apart. Read on.